TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Global Cord Blood ( (CORBF) ) has shared an announcement.
On December 1, 2025, the joint provisional liquidators of Global Cord Blood Corporation submitted their fourteenth report to the Grand Court of the Cayman Islands. This report is part of an ongoing process following the court’s appointment of liquidators in September 2022, reflecting the company’s continued efforts to manage its financial restructuring. The publication of this report is significant for stakeholders as it provides updates on the company’s liquidation process and its implications for creditors and investors.
More about Global Cord Blood
Global Cord Blood Corporation operates in the healthcare industry, focusing on the storage of umbilical cord blood stem cells. The company provides services primarily related to the collection, processing, and storage of stem cells for future medical use, serving a market interested in regenerative medicine and potential future therapies.
Average Trading Volume: 19,198
Technical Sentiment Signal: Sell
Current Market Cap: $127.2M
For an in-depth examination of CORBF stock, go to TipRanks’ Overview page.